Val sheet + Key publications: Key data & publications this week for EU Pharma, Biotech & Life Sc.: Updated valuation pack for 10/07/26, Key publications: (1.) Sector compiled Preview book (2.) AZN Wainua ATTR-CM Phase 3 miss (3.) ROP Q2 preview (4.) NOVN Myricx acqn (5.) IPN Dysport p

Research evidence excerpt

Val sheet + Key publications: Key data & publications this week for EU Pharma, Biotech & Life Sc.: Updated valuation pack for 10/07/26, Key publications: (1.) Sector compiled Preview book (2.) AZN Wainua ATTR-CM Phase 3 miss (3.) ROP Q2 preview (4.) NOVN Myricx acqn (5.) IPN Dysport p

eakers: Any views or opinions expressed by third-party speakers during a

Barclays-hosted event are solely those of the speaker and do not represent the views or opinions of Barclays. Barclays is not responsible for, and

makes no warranties whatsoever as to, the information or opinions contained in any written, electronic, audio or video presentations by any third-

party speakers, and such presentations have not been adopted or endorsed by Barclays and do not represent the views or opinions of Barclays.

Content from third-party presentations is provided for information purposes only and has not been independently verified by Barclays for its accuracy

or completeness.

The views in this publication are solely and exclusively those of the authoring analyst(s) and are subject to change, and Barclays Research has no

obligation to update its opinions or the information in this publication. Unless otherwise disclosed herein, the analysts who authored this report have

not received any compensation from the subject companies in the past 12 months. If this publication contains recommendations, they are general

recommendations that were prepared independently of any other interests, including those of Barclays and/or its affiliates, and/or the subject

companies. This publication does not contain personal investment recommendations or investment advice or take into account the individual financial

circumstances or investment objectives of the clients who receive it.